FDA Orange Book · active-ingredient family
Iopromide
Iopromide is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ULTRAVIST (PHARMACY BULK) · NDA 021425
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ULTRAVIST (PHARMACY BULK)RLD×3 | BAYER HLTHCARE | NDA 021425 | — | Mar 12, 2004 | |
| ULTRAVIST 150RLD×5 | BAYER HLTHCARE | NDA 020220 | — | May 10, 1995 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Iopromide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

